Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

LGND Ligand Pharmaceuticals

86.110
+0.540+0.63%
Close 09/30 16:00 ET
86.1100.0000.00%
Post Mkt Price 09/30 16:06 ET
High
89.520
Open
86.270
Turnover
10.51M
Low
85.960
Pre Close
85.570
Volume
120.58K
Market Cap
1.45B
P/E(TTM)
Loss
52wk High
169.980
Shares
16.88M
P/E(Static)
26.02
52wk Low
72.570
Float Cap
1.36B
Bid/Ask %
-42.86%
Historical High
278.620
Shs Float
15.81M
Volume Ratio
0.85
Historical Low
6.600
Dividend TTM
--
Div Yield TTM
--
P/B
1.81
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.76%
Amplitude
4.16%
Avg Price
87.199
Lot Size
1
Float Cap
1.36B
Bid/Ask %
-42.86%
Historical High
278.620
Shs Float
15.81M
Volume Ratio
0.85
Historical Low
6.600
Dividend TTM
--
P/B
1.81
Dividend LFY
--
Turnover Ratio
0.76%
Amplitude
4.16%
Avg Price
87.199
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Emeryville, CA.
CEO: Mr. John L. Higgins
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...